US Stocks
/
ADC Therapeutics SA Share Price

ADC Therapeutics SA Share Price

NYSE: ADCT | Micro Cap
$1.42
+$0.15 (11.86%) Last updated on 08 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

ADC Therapeutics SA Stock Performance

Open
$1.25
Prev. Close
$1.26
Circuit Range
N/A
Day Range
$1.25 - $1.44
Year Range
$0.78 - $4.96
Volume
48,504
Average Traded
$1.38

ADC Therapeutics SA Share Price Today

As of 8 October 2026, ADC Therapeutics SA's share price is $1.42. The stock opened at $1.25, compared to its previous close of $1.26. During today's trading session, ADC Therapeutics SA's share price traded between $1.25 and $1.44, with an average price of $1.34. Over the past 52 weeks, the stock has recorded a high of $4.96 and a low of $0.78. In terms of performance, ADC Therapeutics SA's share price has declined by 62.52% over the last six months and is down 68.24% on a year-on-year basis.

ADC Therapeutics SA Share Price Chart

$1.25$1.44
L
Show Current Price
H

ADC Therapeutics SA Stock Fundamentals & Key Indicators

Market Cap
$179.80M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.76
Revenue (TTM)
$81.36B
Return On Equity (TTM)
42.47%
Profit Margin
-175.29%
Debt to Equity
-0.51
Quarterly Earnings Growth YoY
59.56%

ADC Therapeutics SA Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$16.43$23.06$20.85$19.25
Net Profit-$40.97-$6.41-$32.97-$16.57
Net Profit Margin-249.36%-27.80%-158.13%-86.08%
Income ChangeN/A84.35%-414.35%49.74%

ADC Therapeutics SA Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$209.91$69.56$70.84$81.36
Net Profit-$157.13-$240.05-$157.85-$142.62
Net Profit Margin-74.86%-345.10%-222.83%-175.29%
Income ChangeN/A-52.77%34.24%9.65%

About ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. Additionally, the company's development pipeline comprises LOTIS-2, LOTIS-5, LOTIS-7, and ADCT-241, being developed as potential therapies for different cancer diseases. Geographically, the firm generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

ADC Therapeutics SA Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.19
$1.43
+17.77%
Sep 2026
$1.17
$1.21
+8.52%
Aug 2026
$1.06
$1.11
+6.19%
Jul 2026
$1.07
$1.05
-0.94%
Jun 2026
$3.42
$1.06
-68.82%
May 2026
$3.77
$3.40
-9.93%
Apr 2026
$3.75
$3.77
+0.80%
Mar 2026
$3.99
$3.75
-8.66%
Feb 2026
$3.65
$4.10
+13.26%
Jan 2026
$3.50
$3.62
+2.40%
Dec 2025
$4.26
$3.54
-17.79%
Nov 2025
$4.37
$4.30
-3.48%

ADCT Share Price FAQs

What is ADC Therapeutics SA share price today?

chevron-up
ADC Therapeutics SA share price today is $1.42 as on October 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of ADC Therapeutics SA stock?

chevron-up
The 52 week high of ADC Therapeutics SA stock is $4.96, while the 52 week low is $0.78 as of 8 Oct '26.

What is ADCT's market capitalisation today?

chevron-up
ADCT market capitalisation is $179.80M as of October 8, 2026, at 4:08 pm IST.

What is ADCT's net income for the last quarter?

chevron-up
ADCT's net income for the last quarter is -16.57B USD.

What is the 5 year returns of ADCT?

chevron-up
The 5 year returns of ADCT is -95.13% as on 8 Oct '26.

What is the high & low stock price of ADCT today?

chevron-up
ADCT stock price hit a high of $1.44 and low of $1.25 as of 8 Oct '26.

Can I buy ADCT shares in India?

chevron-up
Yes. You can buy ADCT in India by opening an international trading account.